查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950523

帕金森氏症監測設備市場按產品類型、技術、最終用戶和分銷管道分類，全球預測（2026-2032年）

Parkinson's Disease Monitoring Device Market by Product Type, Technology, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年帕金森氏症監測設備市場價值為 2.3747 億美元，預計到 2026 年將成長至 2.6292 億美元，到 2032 年將達到 4.4091 億美元，複合年成長率為 9.24%。

關鍵市場統計數據
基準年 2025 2.3747億美元
預計年份：2026年 2.6292億美元
預測年份 2032 4.4091億美元
複合年成長率 (%) 9.24%

隨著臨床醫生、患者和技術提供者逐漸達成共識，帕金森氏症監測設備的發展日新月異，他們開始尋求遠端、客觀地測量運動和非運動症狀。新型感測器技術、訊號處理技術的進步以及日益複雜的資料架構，使得持續的症狀追蹤成為可能，從而能夠補充臨床評估。這些功能正在重塑治療路徑，使早期療育成為可能，最佳化藥物劑量，並以高解析度的數位終點支持臨床試驗。

在此背景下，相關人員正努力應對動態的監管和報銷環境，該環境要求產品具備可證實的臨床療效，並能與電子健康記錄系統互通性。設備外形、病患接受度以及與臨床工作流程的整合程度都會影響其應用。最終，市場將重點放在檢驗的療效、以患者為中心的設計以及可擴展的數據管理上，從而為製造商、服務供應商和醫療保健系統創造機會，使其能夠在疾病管理和研究效率方面實現可衡量的改進。

感測器技術、人工智慧和不斷發展的臨床實踐的進步正在加速和重新定義帕金森氏症監測策略的採用。

近年來，技術的成熟和臨床需求的轉變共同推動了該領域的變革。感測器小型化和電池續航力的提升，使得外形規格從固定式擴展到穿戴式植入設備，從而能夠在真實環境中持續採集步態、震顫和電生理訊號。同時，資料分析（尤其是機器學習和人工智慧）技術的進步，提高了從雜訊較大的縱向資料集中提取具有臨床意義特徵的準確性，從而實現了個性化的症狀分析和預測分析，進而指南治療方案的調整。

評估2025年美國關稅調整對醫療設備生態系統供應鏈、採購和分銷策略的策略性連鎖反應。

影響跨境貿易的政策行動會透過改變零件成本、供應商選擇和分銷經濟效益，對帕金森氏症監測設備生態系統產生重大影響。美國在2025年實施的關稅調整迫使製造商和採購團隊重新評估其關鍵零件的籌資策略，例如加速計、陀螺儀、肌電圖感測器以及嵌入穿戴式裝置和非穿戴式裝置中的半導體元件。因此，設備設計人員越來越重視供應鏈的韌性和供應商多元化，以降低貿易相關成本波動所帶來的風險。

產品類型、終端用戶環境、分銷管道和底層技術等方面的細緻細分將如何決定差異化的開發和商業化路徑

基於細分市場的洞察揭示了不同產品類型、最終用戶、分銷管道和底層技術所呈現的獨特發展和應用路徑。非穿戴式裝置和穿戴式裝置之間的差異決定了設計重點和臨床應用場景。非穿戴式設備，例如行動應用、固定系統和桌面設備，往往強調實驗室層級的精確度和與臨床工作流程的整合。而穿戴式解決方案，例如鞋類穿戴設備、植入式設備和腕戴式設備，則優先考慮持續的實際環境監測和患者舒適度。在植入式技術中，深部腦部刺激系統和神經刺激設備佔據著一個高度複雜且監管嚴格的細分市場，需要進行外科手術和長期追蹤。而腕戴式設備，分為健身手環和智慧型手錶，則兼顧了消費者友善的人體工學設計和臨床級別的感測功能。

區域趨勢和醫療保健體係差異正在導致全球市場採納、監管要求和市場進入策略的差異。

區域趨勢正在影響美洲、歐洲、中東和非洲以及亞太地區的技術採納、監管預期和報銷方式，為醫療器材開發商帶來不同的機會和挑戰。在美洲，強大的臨床研究基礎設施和對價值醫療日益成長的關注推動了早期臨床檢驗和私人支付方的參與，而北美製造和分銷中心則影響著採購決策和市場進入時機。在歐洲、中東和非洲，區域​​監管協調框架和對臨床證據的重視正在推動系統性的採納曲線，該曲線評估那些展現出互通性和長期療效的醫療器材。

硬體製造商、感測器供應商、分析技術先驅和臨床研究合作夥伴之間的競爭與合作動態推動了產品差異化。

對主要企業的深入分析表明，成熟的醫療設備製造商、專業感測器供應商、數位醫療Start-Ups和專注於研究的測量設備製造商能夠提供互補的能力。現有醫療設備公司傾向於利用其深厚的臨床關係和監管經驗，將植入式和臨床級固定系統推向市場。同時，新參與企業和科技公司正在推動穿戴式裝置和麵向消費者的介面（便於家庭監測）的開發。感測器製造商提供底層硬體，例如加速計、陀螺儀和肌電圖 (EMG) 感測器，這些硬體的品質直接影響訊號保真度和分析性能，因此與供應商建立策略夥伴關係至關重要。

制定切實可行的策略重點和營運措施，以增強韌性、加速臨床應用並創造差異化的價值提案

產業領導者可以採取一系列切實可行的措施來鞏固市場地位、加速產品推廣並降低營運風險。首先，優先考慮臨床檢驗和互通性可以減少醫院、神經科診所和研究機構採用該產品的障礙。投資於同行評審的研究並加強與電子健康記錄 (EHR) 的整合能力，可以提高可靠性和易用性。其次，透過雙源採購、戰略庫存緩衝以及盡可能採用近岸外包來建立具有韌性的供應鏈，可以降低關稅引起的成本波動和零件短缺的風險。這些措施有助於維持生產的連續性，並防止成本突然上漲。

透明且可複製的調查方法結合了深度訪談、技術評估和跨細分市場分析，以確保獲得基於證據的見解。

本分析的調查方法結合了定性和定量證據收集，以確保研究結果的可靠性和可重複性。主要研究包括對臨床醫生、採購負責人、醫療設備工程師和臨床試驗申辦者進行結構化訪談，以獲取有關臨床效用、易用性和採購因素的第一手資訊。此外，還對設備的外形尺寸和感測器規格進行了技術評估，為比較其在實際應用中的保真度和適用性提供了基礎。次要研究則利用了監管指南、同行評審的臨床文獻和公開的技術文件來檢驗臨床和技術方面的論點。

臨床、技術和商業性需求的整合將決定帕金森氏症監測技術領域不斷發展的格局中的最終贏家。

總之，帕金森氏症監測設備生態系統正處於一個轉折點，技術能力、對長期客觀數據的臨床需求以及不斷變化的商業性動態在此交匯融合。在此環境下取得成功，需要設備設計與終端使用者工作流程高度契合，擁有強力的臨床效用證據，並制定能夠反映當地監管和報銷實際情況的適應性商業策略。隨著關稅調整等政策措施對零件成本和生產決策產生影響，供應鏈韌性和策略採購決策的重要性日益凸顯。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 帕金森氏症監測設備市場（依產品類型分類）

  • 非穿戴式裝置
    • 行動應用
    • 靜止系統
    • 桌面設備
  • 穿戴式裝置
    • 鞋類穿戴裝置
    • 植入式裝置
      • 深部腦部刺激
      • 神經刺激設備
    • 腕戴式穿戴裝置
      • 健身手環
      • 智慧型手錶

9. 按技術分類的帕金森氏症監測設備市場

  • 數據分析技術
    • 人工智慧演算法
    • 機器學習
  • 感測器技術
    • 加速計
    • 肌電感測器
    • 陀螺儀

第10章 帕金森氏症監測設備市場（依最終用戶分類）

  • 居家照護環境
    • 輔助住宅
    • 病人家
  • 醫院和診所
    • 綜合醫院
    • 神經內科診所
  • 研究所
    • 生技公司
    • 大學

第11章 帕金森氏症監測設備市場（依通路分類）

  • 線下銷售
    • 向醫院銷售
    • 專賣店
  • 線上銷售
    • 直銷
    • 第三方零售商

12. 各地區帕金森氏症監測設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 帕金森氏症監測設備市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國帕金森氏症監測設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國帕金森氏症監測設備市場

第16章：中國帕金森氏症監測設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Biogen Inc.
  • BlueSky Medical Group
  • Boston Scientific Corporation
  • Byteflies NV
  • Clario
  • Cleveland Medical Devices Inc.
  • Gait Up SA
  • GE Healthcare, Inc.
  • Global Data Sciences Inc.
  • Great Lakes NeuroTechnologies, Inc.
  • Koneksa Health Corporation
  • Koninklijke Philips NV
  • MC10 Inc.
  • Medtronic plc
  • mHealth Technologies Srl
  • NeuroMetrix, Inc.
  • PKG Health Ltd.
  • Roche Holding AG
  • Siemens Healthineers AG
  • uMotif Limited
  • Verily Life Sciences LLC
Product Code: MRR-4F7A6D4FD8BA

The Parkinson's Disease Monitoring Device Market was valued at USD 237.47 million in 2025 and is projected to grow to USD 262.92 million in 2026, with a CAGR of 9.24%, reaching USD 440.91 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 237.47 million
Estimated Year [2026] USD 262.92 million
Forecast Year [2032] USD 440.91 million
CAGR (%) 9.24%

The evolution of Parkinson's disease monitoring devices has accelerated as clinicians, patients, and technology providers converge on remote, objective measurement of motor and non-motor symptoms. New sensor modalities, advances in signal processing, and increasingly sophisticated data architectures now enable continuous symptom tracking that complements clinical assessment. These capabilities are reshaping care pathways by enabling earlier intervention, improving medication titration, and supporting clinical trials with high-resolution digital endpoints.

Against this backdrop, stakeholders are navigating a dynamic regulatory and reimbursement environment that demands demonstrable clinical validity and interoperability with electronic health records. Adoption is influenced by device form factors, patient acceptance, and integration into clinical workflows. The cumulative effect is a market that prioritizes validated outcomes, patient-centric design, and scalable data management-creating opportunities for manufacturers, service providers, and healthcare systems to deliver measurable improvements in disease management and research efficiency.

How sensor advances, artificial intelligence, and clinical practice evolution are jointly accelerating adoption and redefining monitoring strategies for Parkinson's disease

Recent years have witnessed transformative shifts in the landscape driven by converging technological maturity and shifting clinical priorities. Sensor miniaturization and improvements in battery life have broadened viable form factors from stationary systems to wearable and implantable devices, allowing continuous capture of gait, tremor, and electrophysiological signals in real-world contexts. Parallel progress in data analysis-especially machine learning and AI-has improved the extraction of clinically meaningful features from noisy, longitudinal datasets, enabling personalized symptom profiling and predictive analytics that inform therapy adjustments.

Clinically, there has been a transition from episodic, clinic-based assessments toward longitudinal monitoring that reflects day-to-day variability. This shift elevates the role of home-based monitoring in therapeutic decision-making and in decentralized clinical trials. Health systems and payers are increasingly focused on outcomes and value, which pressures vendors to demonstrate clinical utility and cost-effectiveness. Moreover, interoperability expectations have risen; devices must integrate securely with care platforms and electronic health records while meeting privacy and regulatory requirements. In response, partnerships across medical device companies, technology providers, and clinical institutions have become strategic imperatives, accelerating product maturation and adoption pathways.

Assessing the strategic ripple effects of United States tariff changes in 2025 on supply chains, sourcing choices, and distribution strategies across the device ecosystem

Policy measures affecting cross-border trade can materially influence the Parkinson's disease monitoring device ecosystem by altering component costs, supplier selection, and distribution economics. Changes to tariffs implemented in the United States in 2025 have generated a need for manufacturers and procurement teams to reassess sourcing strategies for critical components such as accelerometers, gyroscopes, EMG sensors, and semiconductor elements embedded in wearable and non-wearable devices. As a result, device designers are placing elevated emphasis on supply chain resilience and supplier diversification to mitigate exposure to trade-related cost volatility.

In addition, tariffs have implications for the competitive landscape. Domestic assembly or nearshoring becomes a more attractive proposition for companies seeking to avoid import duties, which may accelerate investments in regional manufacturing capacity. Distribution channels also adapt; hospital buyers and specialty retailers evaluate total landed cost and lead times, while online direct sales models can provide alternative routes to market that reduce intermediary costs. For research institutes and biotech firms reliant on imported instrumentation, procurement timelines and depreciation assumptions are being revisited. Collectively, these dynamics contribute to strategic shifts in procurement, production footprint decisions, and partnership models across the ecosystem, underscoring the need for agile commercial and operational responses.

How nuanced segmentation across product types, end-user settings, distribution channels, and enabling technologies determines differentiated development and commercialization pathways

Segmentation-driven insight reveals distinct development and adoption pathways across product types, end users, distribution channels, and enabling technologies. Product type distinctions between non-wearable and wearable devices shape design priorities and clinical use cases: non-wearable categories such as mobile apps, stationary systems, and tabletop devices often emphasize laboratory-grade fidelity and integration into clinical workflows, whereas wearable solutions including footwear wearables, implantable devices, and wrist-worn wearables prioritize continuous, real-world monitoring and patient comfort. Within implantable technologies, deep brain stimulation systems and neurostimulators occupy a high-complexity, high-regulation niche requiring surgical pathways and long-term follow-up, while wrist-worn wearables split into fitness bands and smart watches that balance consumer ergonomics with clinical-grade sensing.

End-user segmentation likewise dictates deployment models and product requirements. Home care settings, which encompass assisted living facilities and patient homes, demand ease of use, remote management capabilities, and battery longevity. Hospitals and clinics, ranging from general hospitals to neurology clinics, prioritize integration into electronic health records, clinical validation, and workflow compatibility. Research institutes, including biotech firms and universities, require flexible, high-resolution data capture and interoperability with analytic pipelines for trial endpoints. Distribution channel nuances influence commercialization pathways; offline sales through hospital procurement and specialty stores typically involve clinical evaluation cycles and institutional contracting, while online channels-via direct sales and third-party retailers-favor scalable marketing, streamlined logistics, and faster patient access. Finally, technology segmentation highlights the centrality of data analysis and sensor technology: data analysis technologies such as AI algorithms and machine learning are critical to converting raw signals into actionable clinical insights, while sensor components like accelerometers, EMG sensors, and gyroscopes determine the fidelity and types of signals available for analysis. Taken together, these segmentation lenses inform prioritized investment, regulatory strategies, and go-to-market approaches tailored to device form factor, care setting, and user needs.

Regional dynamics and healthcare system variations that shape differential adoption, regulatory requirements, and go-to-market strategies across global markets

Regional dynamics affect technology adoption, regulatory expectations, and reimbursement approaches across the Americas, Europe, Middle East & Africa, and Asia-Pacific, creating varied opportunities and constraints for device developers. In the Americas, strong clinical research infrastructure and a growing emphasis on value-based care foster early clinical validation and private payer engagement, while North American manufacturing and distribution hubs influence sourcing decisions and market entry timing. Transitioning to Europe, Middle East & Africa, regulatory harmonization through regional frameworks and an emphasis on clinical evidence drive a methodical adoption curve that rewards devices demonstrating interoperability and long-term outcomes.

By contrast, the Asia-Pacific region presents a heterogeneous environment where rapid digital health adoption in certain markets coexists with varying regulatory maturity and pricing pressures. Local manufacturing capabilities and government-driven initiatives to expand access to digital health services are significant factors in commercialization planning. Across regions, differences in clinician workflows, patient engagement norms, and health system reimbursement mechanisms require tailored go-to-market strategies. Strategic partners and local clinical champions play a crucial role in navigating these regional nuances and accelerating acceptance among providers and patients.

Competitive and collaborative dynamics among hardware manufacturers, sensor suppliers, analytics pioneers, and clinical research partners driving product differentiation

A focused review of key companies reveals a mix of established medical device manufacturers, specialized sensor suppliers, digital health start-ups, and research-focused instrument makers contributing complementary capabilities. Established medical device firms typically leverage deep clinical relationships and regulatory experience to bring implantable and clinical-grade stationary systems to market, while newer entrants and technology companies advance wearable form factors and consumer-friendly interfaces that facilitate home monitoring. Sensor manufacturers provide the foundational hardware-accelerometers, gyroscopes, and EMG sensors-whose quality directly affects signal fidelity and analytic performance, making supplier partnerships strategically important.

Additionally, companies offering data analytics and AI capabilities are critical for translating multi-modal sensor data into clinically actionable metrics. Research institutes and biotech firms engage with device vendors to validate digital biomarkers and incorporate monitoring solutions into trials, thereby influencing product roadmaps and evidence generation. Across the competitive landscape, collaboration between hardware vendors, software developers, clinical research organizations, and health systems is increasingly common, enabling bundled solutions that address clinical validation, data governance, and deployment. Observing these interdependencies helps stakeholders identify potential partners, acquisition targets, and areas for differentiated investment.

Practical strategic priorities and operational measures to enhance resilience, accelerate clinical adoption, and create differentiated value propositions

Industry leaders can take a series of pragmatic steps to strengthen market position, accelerate adoption, and reduce operational risk. First, prioritizing clinical validation and interoperability will mitigate adoption barriers among hospitals, neurology clinics, and research institutions; investing in peer-reviewed studies and integration capabilities with electronic health records enhances credibility and practical utility. Second, establishing resilient supply chains through dual sourcing, strategic inventory buffers, and nearshoring where feasible will reduce exposure to tariff-driven cost fluctuations and component shortages. These actions support continuity in production and guard against sudden cost escalation.

Third, commercial strategies should reflect end-user needs: solutions for home care settings must emphasize ease of use, long battery life, and remote management, whereas hospital-focused offerings should prioritize data accuracy, regulatory compliance, and workflow integration. Fourth, building partnerships with regional distributors, clinical networks, and research institutes can expedite local market entry and evidence generation. Fifth, technology roadmaps must balance sensor fidelity and analytic sophistication with privacy-by-design and robust cybersecurity practices to satisfy regulators and payers. Finally, considering bundled service models that combine devices with analytics and clinician support can create differentiated value propositions and recurring revenue pathways. Implementing these recommendations will help organizations navigate uncertainty while positioning for sustainable growth.

Transparent, reproducible methodology combining primary interviews, technical assessments, and cross-segmentation analysis to ensure evidence-based insights

The research methodology underpinning this analysis combined qualitative and quantitative evidence gathering to ensure robust, reproducible insights. Primary research included structured interviews with clinicians, procurement officers, device engineers, and clinical trial sponsors to capture first-hand perspectives on clinical utility, usability, and procurement drivers. Supplementing this, technical assessments of device form factors and sensor specifications provided comparative context for fidelity and real-world suitability. Secondary research drew on regulatory guidance, peer-reviewed clinical literature, and publicly available technical documentation to validate clinical and technical claims.

Analytical approaches involved cross-segmentation mapping to identify correlations between product type, end-user requirements, distribution channels, and enabling technologies. Scenario analysis explored supply chain and policy sensitivities, including tariff-related impacts on component sourcing and manufacturing footprints. Throughout, emphasis was placed on triangulating findings across sources to reduce bias and highlight areas where evidence is strong versus where further validation is advisable. The methodology is designed to be transparent and replicable, enabling clients to trace insights back to source inputs and to request deeper dives into specific segments or geographies as needed.

Synthesis of clinical, technical, and commercial imperatives that will determine winners in the evolving landscape of Parkinson's disease monitoring technologies

In conclusion, the Parkinson's disease monitoring device ecosystem is at an inflection point where technological capability, clinical demand for longitudinal objective data, and evolving commercial dynamics converge. Success in this environment requires a clear alignment between device design and end-user workflows, strong clinical evidence of utility, and adaptive commercial strategies that reflect regional regulatory and reimbursement realities. Supply chain resilience and strategic sourcing decisions are increasingly material as policy actions such as tariff adjustments influence component costs and manufacturing decisions.

Looking ahead, organizations that invest in interoperable architectures, prioritize patient-centric design, and cultivate partnerships across clinical and research communities will be best positioned to capture the clinical and commercial advantages of continuous monitoring. By integrating validated analytics and robust data governance practices, developers can build trust with clinicians and payers, supporting broader adoption and enabling more personalized, data-driven care for people living with Parkinson's disease.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Parkinson's Disease Monitoring Device Market, by Product Type

  • 8.1. Non-Wearable Devices
    • 8.1.1. Mobile Apps
    • 8.1.2. Stationary Systems
    • 8.1.3. Tabletop Devices
  • 8.2. Wearable Devices
    • 8.2.1. Footwear Wearables
    • 8.2.2. Implantable Devices
      • 8.2.2.1. Deep Brain Stimulation
      • 8.2.2.2. Neurostimulators
    • 8.2.3. Wrist-Worn Wearables
      • 8.2.3.1. Fitness Bands
      • 8.2.3.2. Smart Watches

9. Parkinson's Disease Monitoring Device Market, by Technology

  • 9.1. Data Analysis Technology
    • 9.1.1. Ai Algorithms
    • 9.1.2. Machine Learning
  • 9.2. Sensor Technology
    • 9.2.1. Accelerometers
    • 9.2.2. Emg Sensors
    • 9.2.3. Gyroscopes

10. Parkinson's Disease Monitoring Device Market, by End User

  • 10.1. Home Care Settings
    • 10.1.1. Assisted Living Facilities
    • 10.1.2. Patient Homes
  • 10.2. Hospitals And Clinics
    • 10.2.1. General Hospitals
    • 10.2.2. Neurology Clinics
  • 10.3. Research Institutes
    • 10.3.1. Biotech Firms
    • 10.3.2. Universities

11. Parkinson's Disease Monitoring Device Market, by Distribution Channel

  • 11.1. Offline Sales
    • 11.1.1. Hospital Sales
    • 11.1.2. Specialty Stores
  • 11.2. Online Sales
    • 11.2.1. Direct Sales
    • 11.2.2. Third Party Retailers

12. Parkinson's Disease Monitoring Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Parkinson's Disease Monitoring Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Parkinson's Disease Monitoring Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Parkinson's Disease Monitoring Device Market

16. China Parkinson's Disease Monitoring Device Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Biogen Inc.
  • 17.7. BlueSky Medical Group
  • 17.8. Boston Scientific Corporation
  • 17.9. Byteflies NV
  • 17.10. Clario
  • 17.11. Cleveland Medical Devices Inc.
  • 17.12. Gait Up SA
  • 17.13. GE Healthcare, Inc.
  • 17.14. Global Data Sciences Inc.
  • 17.15. Great Lakes NeuroTechnologies, Inc.
  • 17.16. Koneksa Health Corporation
  • 17.17. Koninklijke Philips N.V.
  • 17.18. MC10 Inc.
  • 17.19. Medtronic plc
  • 17.20. mHealth Technologies Srl
  • 17.21. NeuroMetrix, Inc.
  • 17.22. PKG Health Ltd.
  • 17.23. Roche Holding AG
  • 17.24. Siemens Healthineers AG
  • 17.25. uMotif Limited
  • 17.26. Verily Life Sciences LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY MOBILE APPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY MOBILE APPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY STATIONARY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY STATIONARY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY STATIONARY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TABLETOP DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TABLETOP DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TABLETOP DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY FOOTWEAR WEARABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY FOOTWEAR WEARABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY FOOTWEAR WEARABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY FITNESS BANDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY FITNESS BANDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY FITNESS BANDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SMART WATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SMART WATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SMART WATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY AI ALGORITHMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY AI ALGORITHMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY AI ALGORITHMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ACCELEROMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ACCELEROMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ACCELEROMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY EMG SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY EMG SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY EMG SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GYROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GYROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GYROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PATIENT HOMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PATIENT HOMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PATIENT HOMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NEUROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NEUROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY BIOTECH FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY BIOTECH FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITAL SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITAL SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITAL SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY THIRD PARTY RETAILERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY THIRD PARTY RETAILERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY THIRD PARTY RETAILERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 265. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 268. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 269. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 270. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 271. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 272. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)

TABLE 2